期刊
CYTOKINE & GROWTH FACTOR REVIEWS
卷 59, 期 -, 页码 71-83出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2021.01.007
关键词
Serum amyloid A; Autophagy; Cancer; Inflammation; Cell signalling; Treatment resistance
资金
- National Research Foundation (NRF) of South Africa [118566]
Chronic inflammation plays a crucial role in tumor progression and metastasis, with dysregulation of key physiological processes such as autophagy contributing to unfavorable immune responses. Serum amyloid A (SAA) in high levels in the tumor microenvironment can promote cancer initiation and progression by activating signaling pathways like PI3K and MAPK. Autophagy, on the other hand, can have both promoting and inhibiting effects on cancer development, and its regulation is crucial for improving cancer therapy outcomes.
Chronic inflammation, systemic or local, plays a vital role in tumour progression and metastasis. Dysregulation of key physiological processes such as autophagy elicit unfavourable immune responses to induce chronic inflammation. Cytokines, growth factors and acute phase proteins present in the tumour microenvironment regulate inflammatory responses and alter crosstalk between various signalling pathways involved in the progression of cancer. Serum amyloid A (SAA) is a key acute phase protein secreted by the liver during the acute phase response (APR) following infection or injury. However, cancer and cancer-associated cells produce SAA, which when present in high levels in the tumour microenvironment contributes to cancer initiation, progression and metastasis. SAA can activate several signalling pathways such as the PI3K and MAPK pathways, which are also known modulators of the intracellular degradation process, autophagy. Autophagy can be regarded as having a double edged sword effect in cancer. Its dysregulation can induce malignant transformation through metabolic stress which manifests as oxidative stress, endoplasmic reticulum (ER) stress and DNA damage. On the other hand, autophagy can promote cancer survival during metabolic stress, hypoxia and senescence. Autophagy has been utilised to promote the efficiency of chemotherapeutic agents and can either be inhibited or induced to improve treatment outcomes. This review aims to address the known mechanisms that regulate autophagy as well as illustrating the role of SAA in modulating these pathways and its clinical implications for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据